NCT05999968 2026-03-05
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Eli Lilly and Company
Phase 1 Completed
Clinical Trials
6 trialsNCT02630641 2023-05-12
EQUINOXE
Ipsen
Completed
NCT01790126 2020-03-11
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
Aragon Pharmaceuticals, Inc.
Phase 2 Completed
NCT02234089 2019-07-05
ProComD
Ferring Pharmaceuticals
Completed
NCT01729676 2014-07-17
FACT
Ferring Pharmaceuticals
Completed
NCT00626431 2011-07-19
A Study of Leuprolide to Treat Prostate Cancer
Abbott
Phase 3 Completed